UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 262

Sortiert nach

Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease

International psychogeriatrics, 2018-01, Vol.30 (1), p.103-113

2018

Volltextzugriff (PDF)

Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression

Scientific reports, 2021-10, Vol.11 (1), p.20375-20375, Article 20375

2021

Volltextzugriff (PDF)

EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia

European journal of neurology, 2012-09, Vol.19 (9), p.1159-1179

2012

Volltextzugriff (PDF)

EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease

European journal of neurology, 2015-06, Vol.22 (6), p.889-898

2015

Volltextzugriff (PDF)

Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment

Journal of Alzheimer's disease, 2013-01, Vol.33 (3), p.723

2013

Volltextzugriff (PDF)

Predictive and Diagnostic Utility of Brief Neuropsychological Assessment in Detecting Alzheimer's Pathology and Progression to Dementia

Neuropsychology, 2020-11, Vol.34 (8), p.851-861

2020

Volltextzugriff (PDF)

Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment

Acta psychiatrica Scandinavica, 2015-02, Vol.131 (2), p.139-147

2015

Volltextzugriff (PDF)

Improved Automatic Segmentation of White Matter Hyperintensities in MRI Based on Multilevel Lesion Features

Neuroinformatics (Totowa, N.J.), 2017-07, Vol.15 (3), p.231-245

2017

Volltextzugriff (PDF)

ID 326 – Functional connectivity alterations and their relation to pathophysiological changes in mild cognitive impairment

Clinical neurophysiology, 2016-03, Vol.127 (3), p.e126-e127

2016

Volltextzugriff (PDF)

Multimodal imaging in mild cognitive impairment: Metabolism, morphometry and diffusion of the temporal–parietal memory network

NeuroImage (Orlando, Fla.), 2009-03, Vol.45 (1), p.215-223

2009

Volltextzugriff (PDF)

Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer’s disease patients

Brain communications, 2022, Vol.4 (5), p.fcac244-fcac244

2022

Volltextzugriff (PDF)

Drug repositioning and repurposing for Alzheimer disease

Nature reviews. Neurology, 2020-12, Vol.16 (12), p.661

2020

Volltextzugriff (PDF)

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis

Multiple sclerosis, 2009-04, Vol.15 (4), p.448-454

2009

Volltextzugriff (PDF)

Morphometric Changes in the Episodic Memory Network and Tau Pathologic Features Correlate with Memory Performance in Patients with Mild Cognitive Impairment

American journal of neuroradiology : AJNR, 2008-06, Vol.29 (6), p.1183-1189

2008

Volltextzugriff (PDF)

Glial activation and inflammation along the Alzheimer's disease continuum

Journal of neuroinflammation, 2019-02, Vol.16 (1), p.46-46, Article 46

2019

Volltextzugriff (PDF)

Diaschisis after thalamic stroke: a comparison of metabolic and structural changes in a patient with amnesic syndrome

Acta neurologica Scandinavica, 2007-05, Vol.115 (s187), p.68-71

2007

Volltextzugriff (PDF)

Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns

Journal of cerebral blood flow and metabolism, 2021-05, Vol.41 (5), p.1162-1174

2021

Volltextzugriff (PDF)

Mild Cognitive Impairment in Parkinson’s Disease

Current neurology and neuroscience reports, 2011-08, Vol.11 (4), p.371-378

2011

Volltextzugriff (PDF)

Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort

Journal of Alzheimer's disease, 2016-08, Vol.54 (1), p.287

2016

Volltextzugriff (PDF)

White matter lesion severity is associated with reduced cognitive performances in patients with normal CSF A beta 42 levels

Acta neurologica Scandinavica, 2008-12, Vol.118 (6), p.373-378

2008

Volltextzugriff (PDF)

Next-Generation RNA-Sequencing of Serum Small Extracellular Vesicles Discovers Potential Diagnostic Biomarkers for Dementia With Lewy Bodies

The American journal of geriatric psychiatry, 2021-06, Vol.29 (6), p.573-584

2021

Volltextzugriff (PDF)

White matter lesion severity is associated with reduced cognitive performances in patients with normal CSF Aβ42 levels

Acta neurologica Scandinavica, 2008-12, Vol.118 (6), p.373-378

2008

Volltextzugriff (PDF)

Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus

Molecular psychiatry, 2015-12, Vol.20 (12), p.1588-1595

2015

Volltextzugriff (PDF)

Author Correction: Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression

Scientific reports, 2022-10, Vol.12 (1), p.17414-17414, Article 17414

2022

Volltextzugriff (PDF)

Improving validity of the trail making test with alphabet support

Frontiers in psychology, 2023, Vol.14, p.1227578-1227578

2023

Volltextzugriff (PDF)

1 – 25 von 262

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(258)
Mit Volltextzugriff
(224)

Publikationsform

Artikel
(255)
Tagungsberichte
(7)

Sprache

Englisch
(244)
Norwegisch
(37)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease

Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression

EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia

EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease

Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment

Predictive and Diagnostic Utility of Brief Neuropsychological Assessment in Detecting Alzheimer's Pathology and Progression to Dementia

Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment

Improved Automatic Segmentation of White Matter Hyperintensities in MRI Based on Multilevel Lesion Features

ID 326 – Functional connectivity alterations and their relation to pathophysiological changes in mild cognitive impairment

Multimodal imaging in mild cognitive impairment: Metabolism, morphometry and diffusion of the temporal–parietal memory network

Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer’s disease patients

Drug repositioning and repurposing for Alzheimer disease

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis

Morphometric Changes in the Episodic Memory Network and Tau Pathologic Features Correlate with Memory Performance in Patients with Mild Cognitive Impairment

Glial activation and inflammation along the Alzheimer's disease continuum

Diaschisis after thalamic stroke: a comparison of metabolic and structural changes in a patient with amnesic syndrome

Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns

Mild Cognitive Impairment in Parkinson’s Disease

Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort

White matter lesion severity is associated with reduced cognitive performances in patients with normal CSF A beta 42 levels

Next-Generation RNA-Sequencing of Serum Small Extracellular Vesicles Discovers Potential Diagnostic Biomarkers for Dementia With Lewy Bodies

White matter lesion severity is associated with reduced cognitive performances in patients with normal CSF Aβ42 levels

Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus

Author Correction: Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression

Improving validity of the trail making test with alphabet support

Suchergebnisse filtern